+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Acute Pancreatitis Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

Acute Pancreatitis Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 115 Pages
  • Global
From
Myocardial Infarction Global Market Report 2024 - Product Thumbnail Image

Myocardial Infarction Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Autologous Cell Therapy Global Market Report 2024 - Product Thumbnail Image

Autologous Cell Therapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Angina Pectoris Drugs Global Market Report 2024 - Product Thumbnail Image

Angina Pectoris Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Whooping Cough - Pipeline Insight, 2021 - Product Thumbnail Image

Whooping Cough - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021

  • Report
  • December 2021
  • 38 Pages
  • Global
From
Syringe Filling Machine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Syringe Filling Machine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 120 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Drug Sales Forecast - Q1, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Drug Sales Forecast - Q1, 2021

  • Report
  • March 2021
  • 41 Pages
  • Global
From
Global Medical & Clinical Research - Industry Report - Product Thumbnail Image

Global Medical & Clinical Research - Industry Report

  • Report
  • June 2024
  • 1510 Pages
  • Global
From
Dynavax Technologies Corporation (DVAX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Dynavax Technologies Corporation (DVAX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 89 Pages
From
Dynavax Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Dynavax Technologies Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • June 2024
  • 50 Pages
From
Comprehensive Report on Dynavax Technologies Corporation, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Dynavax Technologies Corporation, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2022
  • 52 Pages
From
Loading Indicator